Search Form
First, enter a politician or zip code
Now, choose a category

Key Votes

HB 19-1216 - Limits the Cost of Insulin and Authorizes Insulin-Pricing Study - Colorado Key Vote

Julie McCluskie voted Yea (Concurrence Vote) on this Legislation.

Read statements Julie McCluskie made in this general time period.

Timeline

Issues Related to HB 19-1216

Stage Details

Legislation - Signed (Executive) -

Title: Limits the Cost of Insulin and Authorizes Insulin-Pricing Study

Legislation - Concurrence Vote Passed (House) (53-12) - (Key vote)
See How Your Politicians Voted

Title: Limits the Cost of Insulin and Authorizes Insulin-Pricing Study

Vote Result
Yea Votes
Nay Votes
Vote Smart's Synopsis:

Vote to concur with senate amendments and pass a bill that limits the cost of insulin and authorizes an insulin-pricing study.

Highlights:

 

  • Requires that a carrier that provides coverage for prescription insulin drugs to cap the total amount that a covered person is required to pay for a prescription insulin drug at $100 per 30-day supply (Sec. 2). 

  • Requires the Department of Law to investigate the pricing of prescription insulin drugs and to determine whether additional consumer protections are needed (Sec. 3). 

  • Specifies that this act applies to health coverage plans issued or renewed on or after January 1, 2020, or the date of the official declaration of the vote by the governor, whichever is later (Sec. 5).

  • Appropriates $26,000 to the Department of Regulatory Agencies for use by the Division of Insurance (Sec. 4).

Legislation - Bill Passed With Amendment (Senate) (22-12) - (Key vote)
See How Your Politicians Voted

Title: Limits the Cost of Insulin and Authorizes Insulin-Pricing Study

Vote Result
Yea Votes
Nay Votes
Vote Smart's Synopsis:

Vote to pass an amended bill that limits the cost of insulin and authorizes an insulin-pricing study.

Highlights:

 

  • Requires that a carrier that provides coverage for prescription insulin drugs to cap the total amount that a covered person is required to pay for a prescription insulin drug at $100 per 30-day supply (Sec. 2). 

  • Requires the Department of Law to investigate the pricing of prescription insulin drugs and to determine whether additional consumer protections are needed (Sec. 3). 

  • Specifies that this act applies to health coverage plans issued or renewed on or after January 1, 2020, or the date of the official declaration of the vote by the governor, whichever is later (Sec. 5).

  • Appropriates $26,000 to the Department of Regulatory Agencies for use by the Division of Insurance (Sec. 4).

Legislation - Bill Passed (House) (51-13) -

Title: Limits the Cost of Insulin and Authorizes Insulin-Pricing Study

Legislation - Introduced (House) -

Title: Limits the Cost of Insulin and Authorizes Insulin-Pricing Study

Sponsors

Co-sponsors

Skip to top

Help us stay free for all your Fellow Americans

Just $5 from everyone reading this would do it.

Thank You!

You are about to be redirected to a secure checkout page.

Please note:

The total order amount will read $0.01. This is a card processor fee. Please know that a recurring donation of the amount and frequency that you selected will be processed and initiated tomorrow. You may see a one-time charge of $0.01 on your statement.

Continue to secure page »

Back to top